Drug-drug interactions studies between HCV antivirals sofosbuvir and velpatasvir and HIV antiretrovirals

被引：0
|
作者：
Mogalian, E. [1 ]
Luetkemeyer, A. [2 ]
Naik, S. [3 ]
Natha, M. [3 ]
Stamm, L. [4 ]
Osinusi, A. [4 ]
Shen, G. [1 ]
Sajwani, K. [1 ]
Mcnally, J. [4 ]
Mathias, A. [1 ]
机构：
[1] Clin Pharmacol, Gilead Sci, Foster City, CA USA
[2] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA
[3] Med Affairs, Gilead Sci, Foster City, CA USA
[4] Clin Res, Gilead Sci, Foster City, CA USA
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
WEAB0302
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Drug-drug interaction studies between HCV antivirals sofosbuvir and velpatasvir and HIV antiretrovirals
    Mogalian, E.
    Naik, S.
    Natha, M.
    Stamm, L.
    Shen, G.
    Sajwani, K.
    Osinusi, A.
    McNally, J.
    Matthias, A.
    Chaponda, M.
    Jackson, A.
    [J]. HIV MEDICINE, 2016, 17 : 16 - 16
  • [2] Drug-Drug Interaction Studies between HCV Antivirals Sofosbuvir and GS-5816 and HIV Antiretrovirals
    Mogalian, Erik
    Stamm, Luisa M.
    Osinusi, Anu
    Shen, Gong
    Sajwani, Karim
    McNally, John
    Mathias, Anita
    [J]. HEPATOLOGY, 2015, 62 : 1310A - 1310A
  • [3] Potential for drug-drug interactions between antiretrovirals and HCV direct acting antivirals in a large cohort of HIV/HCV coinfected patient
    Poizot-Martin, Isabelle
    Naqvi, Alissa
    Obry-Roguet, Veronique
    Valantin, Marc-Antoine
    Cuzin, Lise
    Billaud, Eric
    Cheret, Antoine
    Rey, David
    Jacomet, Christine
    Duvivier, Claudine C.
    Pugliese, Pascal
    Pradat, Pierre
    Cotte, Laurent
    [J]. HEPATOLOGY, 2015, 62 : 747A - 748A
  • [4] Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
    Poizot-Martin, Isabelle
    Naqvi, Alissa
    Obry-Roguet, Veronique
    Valantin, Marc-Antoine
    Cuzin, Lise
    Billaud, Eric
    Cheret, Antoine
    Rey, David
    Jacomet, Christine
    Duvivier, Claudine
    Pugliese, Pascal
    Pradat, Pierre
    Cotte, Laurent
    [J]. PLOS ONE, 2015, 10 (10):
  • [5] Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions
    Seden, Kay
    Back, David
    [J]. CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 514 - 526
  • [6] Clinically relevant drug-drug interactions between antiretrovirals and antifungals
    Vadlapatla, Ramya Krishna
    Patel, Mitesh
    Paturi, Durga K.
    Pal, Dhananjay
    Mitra, Ashim K.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (04) : 561 - 580
  • [7] Drug-Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers
    Mogalian, Erik
    Stamm, Luisa M.
    Osinusi, Anu
    Brainard, Diana M.
    Shen, Gong
    Ling, Kah Hiing John
    Mathias, Anita
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 67 (06) : 934 - 940
  • [8] Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy
    Rebecca Lee
    Shyam Kottilil
    Eleanor Wilson
    [J]. Hepatology International, 2017, 11 : 161 - 170
  • [9] Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy
    Lee, Rebecca
    Kottilil, Shyam
    Wilson, Eleanor
    [J]. HEPATOLOGY INTERNATIONAL, 2017, 11 (02) : 161 - 170
  • [10] Pharmacokinetics and drug-drug interactions of antiretrovirals: An update
    Dickinson, Laura
    Khoo, Saye
    Back, David
    [J]. ANTIVIRAL RESEARCH, 2010, 85 (01) : 176 - 189
12345